Evidence map›Paper›PMID 9926944›Full record

ArticleOncogene1999

p16INK4 mediates contact-inhibition of growth.

R J Wieser, D Faust, C Dietrich, F Oesch

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. HPV16 AND EXPRESSION OF PROTEIN P16INK4A AND E7 ONCOPROTEIN IN COLORECTAL CARCINOMA.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2022
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. p16 protein is upregulated in a stepwise fashion in colorectal adenoma and colorectal carcinoma.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2016
    Article
  9. Senescence Mediated by p16Scientific reports · 2016
    Article
  10. Treating cancer with selective CDK4/6 inhibitors.Nature reviews. Clinical oncology · 2016
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

R J WieserInstitut für Toxikologie, Mainz, Germany.
D Faust
C Dietrich
F Oesch
Institut für biologische Forschung · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growth of non-transformed cells in vitro is regulated by density-dependent mechanisms via cell-cell contacts, leading to arrest in late G1-phase at confluency (contact-inhibition of growth). In the present study it is shown that this results from p16INK4-mediated dissociation of the complex cdk4-cyclin D1, which is responsible for the inactivation of the gate keeper of G1-S transition, the retinoblastoma protein pRb. As a consequence of the inactivation of cdk4, downstream the activation of cdk2 and hyperphosphorylation and thus inactivation of pRb was impaired. Direct evidence for the central role of p16INK4 in growth control comes from the observation that a competitive inhibitor of p16INK4 repressed contact inhibition of growth. These findings provide an explanation for the high incidence of mutation or loss of INK4 in human tumours.

Indexed as

CDC2-CDC28 KinasesCell DivisionProto-Oncogene ProteinsAmino Acid SequenceCell LineCyclin D1Cyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent KinasesCyclin EHumansMolecular Sequence DataProtein Serine-Threonine KinasesRetinoblastoma ProteinCDC2-CDC28 KinasesCDK2 protein, humanCDK4 protein, humanCyclin D1Cyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent KinasesCyclin EProtein Serine-Threonine KinasesProto-Oncogene ProteinsRetinoblastoma Protein

Identifiers

PMID9926944
OpenAlexW2093197933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.